KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bionano Genomics (BNGO) Receivables - Other (2021 - 2025)

Bionano Genomics' Receivables - Other history spans 4 years, with the latest figure at $22000.0 for Q4 2024.

  • For Q4 2024, Receivables - Other fell 93.57% year-over-year to $22000.0; the TTM value through Dec 2024 reached $22000.0, down 93.57%, while the annual FY2024 figure was $22000.0, 93.57% down from the prior year.
  • Receivables - Other for Q4 2024 was $22000.0 at Bionano Genomics, down from $342000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $474000.0 in Q4 2022 and bottomed at $22000.0 in Q4 2024.
  • The 4-year median for Receivables - Other is $364500.0 (2021), against an average of $306250.0.
  • The largest annual shift saw Receivables - Other increased 22.48% in 2022 before it crashed 93.57% in 2024.
  • A 4-year view of Receivables - Other shows it stood at $387000.0 in 2021, then rose by 22.48% to $474000.0 in 2022, then fell by 27.85% to $342000.0 in 2023, then plummeted by 93.57% to $22000.0 in 2024.
  • Per Business Quant, the three most recent readings for BNGO's Receivables - Other are $22000.0 (Q4 2024), $342000.0 (Q4 2023), and $474000.0 (Q4 2022).